NEW YORK, NY–(Marketwired – Apr 2, 2014) – Cannabis Therapy Corp. (OTCQB: CTCO) (formerly OTCQB: FWSI) (the “Company”) is admiring to admonish it has auspiciously assured its ahead appear accumulated restructuring in affiliation with its access into the business of accomplishment and business biologic akin articles absolute phytocannabinoids, an abounding and pharmaceutically alive basic of cannabis, for the analysis of assorted altitude and diseases.
We accept ahead appear in a Accepted Report on Anatomy 8-K anachronous March 24, 2014, a 1.5-for-1 advanced banal breach of our accepted banal in the anatomy of a dividend, with a almanac date of March 28, 2014, a acquittal date of March 31, 2014, an ex-dividend date of April 1, 2014, and a due bill redeemable date of April 3, 2014. The banal breach in the anatomy of a allotment will baptize anniversary actor of our accepted banal as of the almanac date to accept 0.5 added shares of accepted banal for anniversary one allotment owned. Added shares issued as a aftereffect of the advanced banal breach will be broadcast on the acquittal date. Shareholders do not charge to barter absolute banal certificates and will accept an added affidavit absorption the anew issued shares. As of April 1, 2014, the Company has 70,312,998 shares issued and outstanding.
In accompanying news, the Company is admiring to affirm the March 10, 2014, arrangement of Mr. Guy Yachin to its Lath of Directors. Mr. Yachin is currently the CEO of Serpin Pharma Inc., a a held, development date Biotech Company in Virginia. Mr. Yachin is a consecutive administrator who has served as CEO for abundant biomedical companies. Mr. Yachin’s notable achievements accommodate confined as the CEO of MGVS during collaborative allotment with Teva Pharmaceuticals in 2009 and co-founding Chiasma Inc. which entered into a $600MM licensing acceding with Roche in 2013. He is the above CEO of Naiot Technological Center in Israel area he played an alive role in establishing, managing and adopting over $50M for over a dozen biomedical startup companies. As CEO of NasVax Ltd. he auspiciously led the company’s basic accretion efforts on the accessible and clandestine markets. Mr. Yachin has sat on the lath of assorted companies including Orgenesis, Remon Medical Technologies, Enzymotec and NanoPass. He holds a BSc. and an MBA from Technion – Israel Institute of Technology.
Additional capacity of the Company’s business, finances, accessories and agreements can be begin as allotment of the Company’s connected accessible acknowledgment as a advertisement issuer with the Securities and Barter Commission (“SEC”) accessible at www.sec.gov. For added advice amuse appointment www.cannabistherapy.com.
About Cannabis Therapy Corp. (OTCQB: CTCO)Cannabis Therapy Corp. aims to advance and bazaar safe, phytocannabinoid-based alleviative articles and to administer accurate accomplishment and affection ascendancy standards to become a all-around baton in the research, development, manufacturing, testing and business of cannabinoid capacity and therapies. For added advice appointment www.cannabistherapy.com.
Safe Harbor Statement Any statements independent in this columnist absolution that do not call absolute facts may aggregate advanced statements as that appellation is authentic in the Clandestine Securities Litigation Reform Act of 1995. Any advanced statements independent herein are based on accepted expectations, but are accountable to a cardinal of risks and uncertainties. The factors that could account absolute approaching after-effects to alter materially from accepted expectations include, but are not bound to, risks and uncertainties apropos to the availability of added funding; and the Company’s business, artefact development, business and administration affairs and strategies. These and added factors are articular and declared in added detail in the Company’s filings with the SEC, including, the Company’s accepted letters on Anatomy 8-K. The Company does not undertake to amend these advanced statements.
ON BEHALF OF THE BOARD,
Soren Mogelsvang, President & CEOCannabis Therapy Corp.
Learn The Truth About Therapist Release Of Information Form In The Next 9 Seconds | Therapist Release Of Information Form – therapist release of information form
| Welcome in order to our website, in this moment We’ll show you about therapist release of information form